References
- Khan G and Hashim MJ: Global burden of deaths from Epstein-Barr virus attributable malignancies 1990–2010. Infect Agents Cancer 9, 38, 2014.
- Young LS and Rickinson AB: Epstein-Barr virus: 40 years on. Nat Rev Cancer 4, 757–768, 2004.
- Ascherio A and Munger KL: Epstein-Barr virus infection and multiple sclerosis: a review. J Neuroimmune Pharmacol 5, 271–277, 2010.
- Boshoff C and Weiss R: AIDS-related malignancies. Nat Rev Cancer 2, 373–382, 2002.
- Zhang Y, Que S, Yang X, Wang B, Qiao L, et al.: Isolation and identification of metabolites from dihydromyricetin. Magn Reson Chem 45, 909–916, 2007.
- Li H, Li Y, Zhang Y, Shi H, Hu W, et al.: Comparison of refluxing, ultrasonic- and microwave-assisted extraction of dihydromyricetin from Ampelopsis grossedentata. J AOAC Int 91, 1278–1283, 2008.
- Qi S, Xin Y, Guo Y, Diao Y, Kou X, et al.: Ampelopsin reduces endotoxic inflammation via repressing ROS-mediated activation of PI3K/Akt/NF-κB signaling pathways. Int Immunopharmacol 12, 278–287, 2012.
- Murakami T, Miyakoshi M, Araho D, Mizutani K, Kambara T, et al.: Hepatoprotective activity of tocha, the stems and leaves of Ampelopsis grossedentata, and ampelopsin. BioFactors (Oxford, England), 21, 175–178, 2004.
- Qi S, Kou X, Lv J, Qi Z, and Yan L: Ampelopsin induces apoptosis in HepG2 human hepatoma cell line through extrinsic and intrinsic pathways: Involvement of P38 and ERK. Environ Toxicol Pharmacol 40, 847–854, 2015.
- Ni F, Gong Y, Li L, Abdolmaleky HM, and Zhou JR: Flavonoid ampelopsin inhibits the growth and metastasis of prostate cancer in vitro and in mice. PloS One 7, e38802, 2012.
- Zhang B, Dong S, Cen X, Wang X, Liu X, et al.: Ampelopsin sodium exhibits antitumor effects against bladder carcinoma in orthotopic xenograft models. Anticancer Drugs 23, 590–596, 2012.
- Elmore S: Apoptosis: a review of programmed cell death. Toxicol Pathol 35, 495–516, 2007.
- Ouyang L, Shi Z, Zhao S, Wang FT, Zhou TT, et al. Programmed cell death pathways in cancer: a review of apoptosis, autophagy and programmed necrosis. Cell Prolif 45, 487–498, 2012.
- Lemke J, von Karstedt S, Zinngrebe J, and Walczak H: Getting TRAIL back on track for cancer therapy. Cell Death Differ 21, 1350–1364, 2014.
- Nair PM, Flores H, Gogineni A, Marsters S, Lawrence DA, et al.: Enhancing the antitumor efficacy of a cell-surface death ligand by covalent membrane display. Proc Natl Acad Sci USA 112, 5679–5684, 2015.
- Zhang X, Chen Y, Jenkins LW, Kochanek PM, and Clark RS: Bench-to-bedside review: Apoptosis/programmed cell death triggered by traumatic brain injury. Crit Care (London, England), 9, 66–75, 2005.
- Park GB, Kim YS, Lee HK, Song H, Cho DH, et al.: Endoplasmic reticulum stress-mediated apoptosis of EBV-transformed B cells by cross-linking of CD70 is dependent upon generation of reactive oxygen species and activation of p38 MAPK and JNK pathway. J Immunol 185, 7274–7284, 2010.
- Koyama S, Koike N, and Adachi S: Expression of TNF-related apoptosis-inducing ligand (TRAIL) and its receptors in gastric carcinoma and tumor-infiltrating lymphocytes: a possible mechanism of immune evasion of the tumor. J Cancer Res Clin Oncol 128, 73–79, 2002.
- Anees M, Horak P, El-Gazzar A, Susani M, Heinze G, et al.: Recurrence-free survival in prostate cancer is related to increased stromal TRAIL expression. Cancer 117, 1172–1182, 2011.
- Perraud A, Akil H, Nouaille M, Petit D, Labrousse F, et al.: Expression of p53 and DR5 in normal and malignant tissues of colorectal cancer: correlation with advanced stages. Oncol Rep 26, 1091–1097, 2011.
- Beier UH, Kaplan B, Setty S, Samuel S, Mathew AV, et al.: Electrolyte imbalances in pediatric living related small bowel transplantation. Transplantation 85, 217–223, 2008.
- Zhuang L, Lee CS, Scolyer RA, McCarthy SW, Zhang XD, et al.: Progression in melanoma is associated with decreased expression of death receptors for tumor necrosis factor-related apoptosis-inducing ligand. Hum Pathol 37, 1286–1294, 2006.
- Xia Z, Dickens M, Raingeaud J, Davis RJ, and Greenberg ME: Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science 270, 1326–1331, 1995.
- Park GB, Jeong JY, and Kim D: Ampelopsin-induced reactive oxygen species enhance the apoptosis of colon cancer cells by activating endoplasmic reticulum stress-mediated AMPK/MAPK/XAF1 signaling. Oncol Lett 14, 7947–7956, 2017.